what i thought was most significant about ann, page-12

ABDM/Surges/GBR and anybody else in the know.

Quick question.

Should the testing be successful, would we expect $ figures at that point or would there be one interim step during or just before the "development and manufacture" phase?

ie. Should we expect details of a licensing deal immediately following successful clinical trials?

Would appreciate the thoughts of those with more experience as this would be my expectation...

Thanks in advance!